This article is more than 5 years old. Information may no longer be current.

FDA approves next-generation ICD/CRT-D devices

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Biotronik announced that the FDA has approved Ilesto DX, a next-generation technology platform for its implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators.

Ilesto DX offers the benefits of the DX System in a thinner and smaller device than previous-generation technologies. The electromechanical platform enables the devices to be 15% smaller and have 29% fewer components than previous-generation devices. In addition, the defibrillator system is equipped to provide full atrial diagnostic information with just one defibrillator lead, instead of two, according to a company press release.